Showing results (161-170 of 172) with videos related to
Sort By:
Pageof 18
Diabetes Care|August 1, 1995
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II DiabetesC Abraira, J A Colwell, F Q Nuttall, et al.Journal of Diabetes and Its Complications|April 15, 2000
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM)N Azad, N V Emanuele, C Abraira, et al.Diabetes Care|October 7, 2000
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial InvestigatorsS R Levin, J W Coburn, C Abraira, et al.Diabetes|May 26, 1999
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft TrialB J Hoogwerf, A Waness, M Cressman, et al.The American Journal of Cardiology|January 4, 2001
Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG InvestigatorsC W White, L Campeau, P Canner, et al.Diabetes Care|September 8, 2000
Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)S U Pitale, C Abraira, N V Emanuele, et al.Diabetes, Obesity & Metabolism|October 11, 2016
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetesK Cusi, A J Sanyal, S Zhang, et al.Journal of Thrombosis and Thrombolysis|June 15, 2001
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatmentJ M Walenga, D Hoppensteadt, R Pifarré, et al.Circulation|June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial InvestigatorsL Campeau, D B Hunninghake, G L Knatterud, et al.Pageof 18